Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail ...
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...
Apple’s latest $500 billion pledge could soften tariff blow, Robinhood is latest to see SEC abandon its crypto case, and more ...
Investing.com -- Novo Nordisk shares climbed more than 3% premarket on Tuesday ... Near Site Conventional Facilities project located at the U.S. Department of Energy's Fermi National Accelerator ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
The NoVo Foundation reported to the IRS that it had $545,384,793 in total assets value at the end of 2023. The organization reported $199,397,422 in contributions, gifts and grants paid. It ...
European shares advanced on Tuesday, as gains in defence stocks outweighed technology losses spurred by concerns over U.S. chip curbs on China. The pan-European STOXX 600 index rose 0.3% by 0930 GMT.
Auchincloss has pledged a root-and-branch overhaul of BP's strategy. The company is in crisis after it revealed profits ...
During the fourth quarter, the Harbor Capital Appreciation Fund returned 6.22%, underperforming its benchmark, the Russell ...